Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Effective management of PCOS includes lifestyle changes, medication for menstrual regulation, fertility treatments, and cosmetic issue remedies.

Further research is needed to develop effective cancer prevention strategies.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The document provides updated advice on how to diagnose and treat polycystic ovary syndrome.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Treating hyperprolactinemia can help manage PCOS symptoms.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Stopping the use of the drug finasteride can improve sperm count and does not prevent normal conception, but caution is advised when trying to conceive.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Blocking androgens at birth reduces sexual motivation in male rats.

Including androgens in hormone therapy may lower breast cancer risk.